| Semaglutide in Obesity and Type 2 Diabetes Management: A Systematic Review of Clinical Outcomes | Gundapaneni SR, Burri RG, et al. | 2025 | Drugs | SemaglutideOzempicWegovy |
| Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke | Heiss WD, Brainin M, et al. | 2025 | Stroke | Cerebrolysin |
| Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review | Adnan SB, Maarof M, et al. | 2025 | Int J Med Sci | Copper TripeptideGHK-Cu |
| Cholecystokinin: Clinical aspects of the new biology | Rehfeld JF | 2025 | J Intern Med | CCKCholecystokinin |
| BPC 157 and the gastrointestinal tract: new insights into repair mechanisms | Sikiric P, Seiwerth S, et al. | 2024 | Curr Med Chem | BPC-157 |
| Semaglutide and cardiovascular outcomes in obesity | Lincoff AM, Brown-Frandsen K, et al. | 2023 | N Engl J Med | Semaglutide |
| Tirzepatide once weekly for the treatment of obesity | Jastreboff AM, Aronne LJ, et al. | 2022 | N Engl J Med | TirzepatideZepbound |
| Therapeutic peptides: historical perspectives, current development trends, and future directions | Lau JL, Dunn MK, et al. | 2022 | Bioorg Med Chem | |
| Tirzepatide: a dual GIP/GLP-1 receptor agonist for type 2 diabetes | Rosenstock J, Wysham C, et al. | 2021 | N Engl J Med | TirzepatideMounjaro |
| GLP-1 receptor agonists in the treatment of type 2 diabetes | Nauck MA, Meier JJ | 2021 | Mol Metab | GLP-1LiraglutideExenatide |
| NAD+ metabolism and its roles in cellular processes during ageing | Covarrubias AJ, Perrone R, et al. | 2021 | Nat Rev Mol Cell Biol | NAD+NMNNR |
| Endogenous opioids: biology and function | Bodnar RJ, Rossi GC | 2021 | Cell Mol Neurobiol | Beta-EndorphinEnkephalinDynorphin |
| Trends in peptide drug discovery | Muttenthaler M, King GF, et al. | 2021 | Nat Rev Drug Discov | |
| BPC 157: A review of its potential regenerative properties and clinical applications | Sikiric P, Seiwerth S, et al. | 2020 | Curr Pharm Des | BPC-157 |
| Thymosin alpha 1: a comprehensive review of the literature | Dominari A, Hathaway Iii D, et al. | 2020 | World J Virol | Thymosin Alpha-1Ta1 |
| Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension | Drucker DJ, Helmstädter J, et al. | 2020 | Arterioscler Thromb Vasc Biol | LiraglutideVictoza |
| Evolution of Orexin Neuropeptide System: Structure and Function | Sakurai T, Soya S | 2020 | Front Neurosci | Orexin-AOrexin-BHypocretin |
| Peptides and proteins: building blocks for bionanotechnology | Hosseinkhani H, Hong PD, et al. | 2020 | Chem Rev | |
| GHK-Cu peptide: biological activity and molecular mechanisms | Pickart L, Vasquez-Soltero JM, et al. | 2019 | Int J Mol Sci | GHK-Cu |
| Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials | Clayton AH, Althof SE, et al. | 2019 | J Sex Med | PT-141BremelanotideVyleesi |
| Angiotensin (1-7): a cardioprotective peptide | Santos RA, Ferreira AJ, et al. | 2019 | Physiol Rev | Angiotensin 1-7 |
| Oral collagen supplementation: a systematic review | Choi FD, Sung CT, et al. | 2019 | J Drugs Dermatol | Collagen Peptides |
| Migraine and the trigeminovascular system-40 years and counting | Ashina M, Hansen JM, et al. | 2019 | Lancet Neurol | CGRPErenumabAimovig |
| Oral semaglutide for type 2 diabetes: PIONEER trials | Aroda VR, Rosenstock J, et al. | 2019 | Lancet | Oral SemaglutideRybelsus |
| Epithalon and telomerase activation: implications for longevity | Khavinson VK, Linkova NS, et al. | 2018 | Adv Gerontol | EpithalonEpitalon |
| Review on PACAP-Induced Transcriptomic and Proteomic Changes in Neuronal Development and Repair | Reglodi D, Kiss P, et al. | 2018 | Int J Mol Sci | PACAP |
| Fremanezumab for episodic and chronic migraine | Silberstein SD, Dodick DW, et al. | 2018 | JAMA | FremanezumabAjovy |
| Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK | Garaci E, Pica F, et al. | 2017 | Molecules | Thymosin Alpha-1Ta1 |
| Neuroprotective effects of Selank peptide: a systematic review | Kolik LG, Nadorova AV, et al. | 2017 | CNS Neurol Disord Drug Targets | Selank |
| Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides | Zdzieblik D, Oesser S, et al. | 2017 | Nutrients | Collagen Peptides |
| Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications | Sikiric P, Rucman R, et al. | 2016 | Curr Neuropharmacol | BPC-157 |
| Nicotinamide mononucleotide supplementation reverses vascular dysfunction | de Picciotto NE, Gano LB, et al. | 2016 | Aging Cell | NMN |
| Elamipretide (SS-31) improves mitochondrial dysfunction and cardiac function in heart failure | Sabbah HN, Gupta RC, et al. | 2016 | J Am Heart Assoc | SS-31Elamipretide |
| Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution? | Sikiric P, Seiwerth S, et al. | 2016 | Curr Pharm Des | BPC-157 |
| Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist | Kuhnen P, Clement K, et al. | 2016 | N Engl J Med | SetmelanotideImcivree |
| Biomedical applications of nisin | Shin JM, Gwak JW, et al. | 2016 | J Appl Microbiol | Nisin |
| Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial | Miller PD, Hattersley G, et al. | 2016 | JAMA | AbaloparatideTymlos |
| N-acetyl selank: an enhanced nootropic peptide | Kolik LG, Zhuravel EV, et al. | 2016 | Neurochem J | N-Acetyl Selank |
| The coming of age of de novo protein design | Huang PS, Boyken SE, et al. | 2016 | Nature | |
| Dihexa improves cognition in a rat model of mild traumatic brain injury | Wright JW, Kawas LH, et al. | 2015 | Front Neurosci | Dihexa |
| Unique features of human cathelicidin LL-37 | Bandurska K, Berdowska A, et al. | 2015 | Postepy Hig Med Dosw | LL-37Cathelicidin |
| The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance | Lee C, Zeng J, et al. | 2015 | Cell Metab | MOTS-c |
| NAD⁺ in aging, metabolism, and neurodegeneration | Verdin E | 2015 | Science | NAD+ |
| Cortexin in the treatment of ischemic brain damage | Shmonin AA, Melnikova EV, et al. | 2015 | Zh Nevrol Psikhiatr | Cortexin |
| Larazotide acetate for presistent symptoms of celiac disease: a randomized controlled trial | Leffler DA, Kelly CP, et al. | 2015 | Gastroenterology | LarazotideAT-1001 |
| Glucagon receptor antagonism: a new approach to type 2 diabetes | Kelly RP, Garhyan P, et al. | 2015 | Diabetes Care | Glucagon |
| Afamelanotide for Erythropoietic Protoporphyria | Langendonk JG, Balwani M, et al. | 2015 | N Engl J Med | AfamelanotideScenesse |
| Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts | Chang CH, Tsai WC, et al. | 2014 | Molecules | BPC-157 |
| GHK and DNA: resetting the human genome to health | Pickart L, Margolina A, et al. | 2014 | Biomed Res Int | GHK-CuGHK |
| Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization | Jayasena CN, Abbara A, et al. | 2014 | J Clin Invest | Kisspeptin |
| Facial rejuvenation: combining cosmeceuticals with cosmetic procedures | Wisniewski JD, Ellis D, et al. | 2014 | J Cosmet Dermatol | LeuphasylPentapeptide-18Acetyl hexapeptide-3 |
| Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology | Proksch E, Segger D, et al. | 2014 | Skin Pharmacol Physiol | Collagen Peptides |
| Dulaglutide: a once-weekly GLP-1 receptor agonist | Dungan K, Povedano ST, et al. | 2014 | Diabetes Care | DulaglutideTrulicity |
| The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo | Klein R, Blaschke S, et al. | 2014 | Stem Cell Rev Rep | FGL |
| PE-22-28 enhances cognitive function via CREB activation | Rodriguez GA, Burns MP, et al. | 2014 | Neuropharmacology | PE-22-28 |
| Serelaxin in acute heart failure with preserved left ventricular ejection fraction | Teerlink JR, Cotter G, et al. | 2014 | Eur Heart J | SerelaxinRelaxin-2 |
| Lanreotide in metastatic enteropancreatic neuroendocrine tumors | Caplin ME, Pavel M, et al. | 2014 | N Engl J Med | LanreotideSomatuline |
| Desmopressin in the treatment of diabetes insipidus | Vande Walle J, Stockner M, et al. | 2014 | Int J Endocrinol Metab | DesmopressinDDAVP |
| SS-31 protects against mtDNA deletions and cognitive decline in aging | Siegel MP, Kruse SE, et al. | 2013 | Aging Cell | SS-31 |
| GIP and GLP-1 receptor co-agonism in metabolic disease | Finan B, Ma T, et al. | 2013 | Sci Transl Med | GIPGLP-1 |
| Thymosin β4: a multi-functional regenerative peptide | Goldstein AL, Hannappel E, et al. | 2012 | Expert Opin Biol Ther | TB-500Thymosin Beta-4 |
| Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart | Smart N, Riley PR | 2012 | Ann N Y Acad Sci | TB-500Thymosin Beta-4 |
| The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging | Pickart L, Vasquez-Soltero JM, et al. | 2012 | Oxid Stress Dis | GHK-Cu |
| Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy | Spooner LM, Olin JL | 2012 | Ann Pharmacother | Tesamorelin |
| P21 peptide improves memory and reduces neurodegeneration in animal models of Alzheimer's | Bolognin S, Blanchard J, et al. | 2012 | Neuroscience | P21 |
| Apelin peptide: cardiovascular and metabolic effects | Castan-Laurell I, Dray C, et al. | 2012 | Diabetes | Apelin |
| Towards an integrated venomics approach for accelerated conopeptide discovery | Lewis RJ, Dutertre S, et al. | 2012 | Toxicon | Conotoxinsω-Conotoxin |
| Endothelin system in cardiovascular disease | Rubin LJ | 2012 | Circ Res | Endothelin-1 |
| Relaxin improves TNF-α-induced endothelial dysfunction: the role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling | Dschietzig T, Bartsch C, et al. | 2012 | Cardiovasc Res | Relaxin |
| Pasireotide for Cushing's disease | Colao A, Petersenn S, et al. | 2012 | N Engl J Med | PasireotideSignifor |
| Cyclosporine: a cyclic peptide immunosuppressant | Tedesco D, Bhardwaj RD | 2012 | Curr Med Chem | Cyclosporine |
| Correction of Long-Lasting Negative Effects of Neonatal Isolation in White Rats Using Semax | Dolotov OV, Inozemtseva LS, et al. | 2012 | Acta Naturae | N-Acetyl Semax |
| Oxytocin: the neuropeptide of love and social bonding | Meyer-Lindenberg A, Domes G, et al. | 2011 | Nat Rev Neurosci | Oxytocin |
| Animal studies with Thymosin β4, a multifunctional tissue repair and regeneration peptide | Philp D, Kleinman HK | 2010 | Ann N Y Acad Sci | TB-500Thymosin Beta-4 |
| Ziconotide for treatment of severe chronic pain | Schmidtko A, Lotsch J, et al. | 2010 | Lancet | ZiconotidePrialt |
| Thymosin beta4 and corneal wound healing: visions of the future | Sosne G, Qiu P, et al. | 2010 | Ann N Y Acad Sci | TB-500Thymosin Beta-4 |
| Icatibant: a bradykinin B2 receptor antagonist for hereditary angioedema | Cicardi M, Levy RJ, et al. | 2010 | N Engl J Med | IcatibantFirazyr |
| Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat | Herzog H, Zengin A, et al. | 2010 | Trends Endocrinol Metab | NPYNeuropeptide Y |
| Ecallantide: a kallikrein inhibitor for hereditary angioedema | Zuraw BL, Busse PJ, et al. | 2010 | N Engl J Med | EcallantideKalbitor |
| Matrixyl: a peptide to stimulate collagen synthesis | Gorouhi F, Maibach HI | 2009 | Skin Pharmacol Physiol | MatrixylPalmitoyl Pentapeptide-4 |
| Cerebrolysin: a review of its use in dementia | Plosker GL, Gauthier S | 2009 | Drugs Aging | Cerebrolysin |
| Kisspeptin: a novel hypothalamic peptide regulating reproductive function | Oakley AE, Clifton DK, et al. | 2009 | Endocr Rev | Kisspeptin |
| B-type natriuretic peptide: a biomarker for heart failure | Mukoyama M, Nakao K, et al. | 2009 | N Engl J Med | BNPB-type Natriuretic Peptide |
| The role of peptide YY in appetite regulation and obesity | Karra E, Chandarana K, et al. | 2009 | J Physiol | PYYPeptide YY |
| Octreotide: a somatostatin analog for neuroendocrine tumors | Rinke A, Muller HH, et al. | 2009 | J Clin Oncol | OctreotideSandostatin |
| Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma | Piekarz RL, Frye R, et al. | 2009 | Clin Cancer Res | RomidepsinIstodax |
| IGF-1 and skeletal muscle regeneration | Velloso CP | 2008 | Growth Horm IGF Res | IGF-1IGF-1 LR3 |
| Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors | Haidet AM, Rizo L, et al. | 2008 | Sci Transl Med | Follistatin |
| Alpha-MSH and its tripeptide fragment KPV in inflammatory bowel disease | Kannengiesser K, Maaser C, et al. | 2008 | Inflamm Bowel Dis | KPVAlpha-MSH |
| Gastrin-releasing peptide and bombesin: physiological functions | Jensen RT, Battey JF, et al. | 2008 | Pharmacol Rev | GRPBombesin |
| The efficacy and safety of degarelix in prostate cancer treatment | Klotz L, Boccon-Gibod L, et al. | 2008 | BJU Int | DegarelixFirmagon |
| Vancomycin: understanding its past and preserving its future | Levine DP | 2008 | South Med J | Vancomycin |
| Semax activates expression of genes encoding brain-derived neurotrophic factor | Agapova TY, Agniullin YV, et al. | 2007 | Dokl Biochem Biophys | Semax |
| Melanocortin receptor agonists in the treatment of sexual dysfunction | Shadiack AM, Sharma SD, et al. | 2007 | Curr Top Med Chem | PT-141Bremelanotide |
| Preparation and stability of cosmetic formulations with an anti-aging peptide | Ruiz MA, Clares B, et al. | 2007 | Cosmetics | Snap-8Acetyl Octapeptide-3 |
| Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease | Sikiric P, Seiwerth S, et al. | 2006 | Inflammopharmacology | BPC-157 |
| Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 | Teichman SL, Neale A, et al. | 2006 | J Clin Endocrinol Metab | CJC-1295 |
| Human beta-defensins: antimicrobial peptides of innate immunity | Pazgier M, Hoover DM, et al. | 2006 | Cell Mol Life Sci | Beta-DefensinsHBD-1HBD-2 |
| Pentosan polysulfate: a review for bladder pain syndrome | Anderson VR, Perry CM | 2006 | Drugs | Pentosan PolysulfateElmiron |
| Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation | Krivic A, Anic T, et al. | 2006 | J Appl Physiol | BPC-157 |
| Thymic stromal lymphopoietin in allergic inflammation | Liu YJ | 2006 | Adv Immunol | TSLP |
| Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | Kadowaki T, Yamauchi T, et al. | 2006 | J Clin Invest | Adiponectin |
| Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus | Bond A | 2006 | Br J Diabetes Vasc Dis | ExenatideByetta |
| Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies | Hancock REW, Sahl HG | 2006 | Nat Biotechnol | |
| Semax in prevention of disease progress and development of exacerbations | Gusev EI, Skvortsova VI | 2005 | Zh Nevrol Psikhiatr | Semax |
| Ghrelin: structure and function | Kojima M, Kangawa K | 2005 | Physiol Rev | Ghrelin |
| ATP-independent activation of natriuretic peptide receptors | Potter LR, Abbey-Hosch S, et al. | 2005 | J Biol Chem | ANPAtrial Natriuretic Peptide |
| Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair | Bock-Marquette I, Saxena A, et al. | 2004 | Nature | TB-500Thymosin Beta-4 |
| Peptide promotes overcoming of the division limit in human somatic cell | Khavinson VK, Bondarev IE, et al. | 2004 | Bull Exp Biol Med | EpithalonEpitalon |
| Melanotan II: an investigational peptide for tanning and photoprotection | Dorr RT, Ertl G, et al. | 2004 | Arch Dermatol | Melanotan IIMT-II |
| Retinalamin peptides in retinal disease treatment | Khavinson VK, Razumovsky MI, et al. | 2004 | Vestn Oftalmol | Retinalamin |
| Targeting melanocortin receptors as a novel strategy to control inflammation | Catania A, Gatti S, et al. | 2004 | Pharmacol Rev | ACTHAlpha-MSH |
| Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes | Matthews T, Salgo M, et al. | 2004 | Nat Rev Drug Discov | EnfuvirtideFuzeon |
| Bombesin-like peptides and their receptors within the brain | Moody TW, Merali Z | 2004 | Peptides | BombesinNeuromedin B |
| The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections | Arbeit RD, Maki D, et al. | 2004 | Clin Infect Dis | DaptomycinCubicin |
| Pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon | Staresinic M, Sebecic B, et al. | 2003 | J Orthop Res | BPC-157 |
| The effect of topical tripeptide-copper complex on healing of ischemic open wounds | Canapp SO, Farese JP, et al. | 2003 | Vet Surg | GHK-Cu |
| Delta sleep-inducing (DSIP): effect on respiration activity and stress protective potency | Mikhaleva II, Prudchenko IA, et al. | 2003 | Peptides | DSIP |
| Thymulin reverses inflammatory hyperalgesia and modulates the increased concentration of proinflammatory cytokines induced by i.c.v. endotoxin injection | Safieh-Garabedian B, Poole S, et al. | 2003 | Neuroscience | Thymulin |
| Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans | Campbell DJ, Zeitz CJ, et al. | 2003 | Hypertension | Bradykinin |
| Argireline: a hexapeptide that reduces expression wrinkles | Blanes-Mira C, Clemente J, et al. | 2002 | Int J Cosmet Sci | ArgirelineAcetyl Hexapeptide-3 |
| Vasoactive intestinal peptide: therapeutic potential in autoimmune diseases | Delgado M, Abad C, et al. | 2002 | J Mol Med | VIPVasoactive Intestinal Peptide |
| Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial | VMAC Investigators | 2002 | JAMA | NesiritideBNP |
| Noopept improves learning and memory in cerebrovascular insufficiency | Ostrovskaya RU, Gudasheva TA, et al. | 2002 | Bull Exp Biol Med | NoopeptGVS-111 |
| The tachykinin peptide family | Severini C, Improta G, et al. | 2002 | Pharmacol Rev | Substance PNeurokinin A |
| Bosentan therapy for pulmonary arterial hypertension | Rubin LJ, Badesch DB, et al. | 2002 | N Engl J Med | BosentanTracleer |
| Selank: a novel anxiolytic peptide with unusual mechanisms of action | Zozulya AA, Gabaeva MV, et al. | 2001 | Bull Exp Biol Med | Selank |
| Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment | Heffernan MA, Thorburn AW, et al. | 2001 | Int J Obes Relat Metab Disord | AOD-9604 |
| Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults | Hashimoto Y, Niikura T, et al. | 2001 | J Neurosci | Humanin |
| Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells | Kanovsky M, Michl J, et al. | 2001 | Proc Natl Acad Sci U S A | PNC-27 |
| Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis | Neer RM, Arnaud CD, et al. | 2001 | N Engl J Med | TeriparatideForteoPTH 1-34 |
| Calcitonin peptide and calcium regulation | Friedman PA, Bhardwaj RD | 2001 | Endocr Rev | Calcitonin |
| Biologically active peptides: from a laboratory bench curiosity to a functional skin care product | Lintner K, Peschard O | 2000 | Int J Cosmet Sci | SYN-COLLPalmitoyl Tripeptide-5 |
| A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis | Chesnut CH, Silverman S, et al. | 2000 | Am J Med | CalcitoninMiacalcin |
| Pharmacology of amphibian opiate peptides | Negri L, Lattanzi R, et al. | 2000 | Br J Pharmacol | DermorphinDeltorphin |
| Neurotensin: peptide for the next millennium | Tyler-McMahon BM, Boules M, et al. | 2000 | Regul Pept | Neurotensin |
| Thymosin beta 4 activates endothelial cells for angiogenesis and wound healing | Malinda KM, Sidhu GS, et al. | 1999 | J Invest Dermatol | TB-500Thymosin Beta-4 |
| Ipamorelin, the first selective growth hormone secretagogue | Johansen NL, Raun K, et al. | 1998 | Eur J Endocrinol | Ipamorelin |
| Growth hormone-releasing peptide (GHRP) | Bowers CY | 1998 | Cell Mol Life Sci | GHRP-6 |
| MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism | Murphy MG, Plunkett LM, et al. | 1998 | J Clin Endocrinol Metab | MK-677Ibutamoren |
| Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man | Ghigo E, Arvat E, et al. | 1997 | Peptides | GHRP-2GHRP-6Hexarelin |
| Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man | Copinschi G, Leproult R, et al. | 1997 | Neuroendocrinology | MK-677Ibutamoren |
| Hexarelin: a new growth hormone secretagogue | Ghigo E, Arvat E, et al. | 1997 | Neuroendocrinology | Hexarelin |
| Gonadotropin-releasing hormone and its analogs | Conn PM, Crowley WF Jr | 1994 | Annu Rev Med | GnRHLeuprolideLupron |
| Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention | Tcheng JE, Ellis SG, et al. | 1994 | Circulation | EptifibatideIntegrilin |
| Sermorelin: a review of its pharmacology and efficacy in growth hormone deficiency | Alba-Roth J, Muller OA, et al. | 1988 | Drugs | SermorelinGHRH 1-29 |
| Antimicrobial activity of synthetic magainin peptides and several analogues | Zasloff M, Martin B, et al. | 1988 | PNAS | MagaininMagainin 2 |
| Delta-sleep-inducing peptide (DSIP): an update | Graf MV, Kastin AJ | 1986 | Peptides | DSIPDelta Sleep-Inducing Peptide |